IPSEN GROUP

Individuals with peripheral motor neuropathic diseases, amyotrophic lateral sclerosis, or neuromuscular junction disorders (e.g., myasthenia gravis or Lambert-Eaton syndrome) should be monitored particularly closely when given botulinum toxin. Patients with neuromuscular disorders may be at increased risk of clinically significant effects including severe dysphagia and respiratory compromise from typical doses of DYSPORT... *In clinical trials, the majority of adults with spasticity or cervical dystonia did not need re-treatment until Weeks 12-16 or Weeks 14-18, respectively, and the majority of pediatric patients with spasticity did not need re-treatment until Weeks 16-28; however, some patients had a longer duration of response. 1... Use our Injector Locator to find specialists near your patients who are trained to administer botulinum toxin, including Dysport. If you are an injector and would like to be added to our search tool, register today to help patients, caregivers, and..